{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:19:26Z","timestamp":1740136766356,"version":"3.37.3"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>In another publication, we concluded endocervical curettage (ECC) should have a minimum number of squamous cells for adequacy, similar to the requirements for adequate cervical Papanicolaou smears. Here, we investigate if also, similar to cervical Papanicolaou smears, the presence of at least 10 cells from the endocervical\/transformation zone (EC\/TZ) in ECCs should be used as a quality assurance measure or if, instead, at least 10 EC\/TZ cells should be part of the adequacy criteria for ECC, with an emphasis on diagnosis of at least high-grade squamous dysplasia (HGD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>All patients with at least HGD diagnosed on an excisional biopsy specimen (loop electrosurgical excision procedure [LEEP]) from May 1, 2018, to December 31, 2019, and an ECC in the preceding 6 months at our institution were included. Number of EC\/TZ cells present in ECCs was counted visually and categorized as less than or greater than 10 TZ cells. A \u03c72 test was used to evaluate the proportion of ECCs with and without HGD and the presence or absence of at least 10 EC\/TZ cells. Given our recent work encouraging at least 1000 squamous cells in an ECC to be considered adequate, we also evaluated only ECCs with greater than 1000 squamous cells with and without HGD and the presence or absence of at least 10 EC\/TZ cells. P value was &amp;lt;.05.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifty-one LEEPs with HGD and a preceding ECC in the previous 6 months were identified. Of the 51 ECCs, 6 had fewer than 10 EC\/TZ cells and 45 had at least 10 EC\/TZ cells. A similar proportion of the ECCs with HGD had at least 10 EC\/TZ cells as those without HGD (93% vs 86%, P = .53). Using only ECCs with greater than 1000 squamous cells, we still found no statistical difference in the proportion of ECCs with HGD having greater than 10 EC\/TZ cells compared to those without HGD (91% vs 100%, P = .49).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We found that the presence of at least 10 EC\/TZ cells does not increase the likelihood of finding HGD in an ECC performed in the 6 months prior to a LEEP with HGD. Similar to the use of the TZ component in cervical Papanicolaou smears, the presence or absence of at least 10 TZ cells in an ECC should only be considered a quality assurance measure and not be used as a criterion for adequacy of the specimen.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqad157","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T01:40:53Z","timestamp":1701394853000},"page":"369-373","source":"Crossref","is-referenced-by-count":0,"title":["Presence of 10 transformation zone cells in endocervical curettage should not be required for adequacy"],"prefix":"10.1093","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5207-1965","authenticated-orcid":false,"given":"Roa","family":"Alqabbani","sequence":"first","affiliation":[{"name":"Department of Pathology, Thomas Jefferson University Hospital , Philadelphia, PA , US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Thomas Jefferson University Hospital , Philadelphia, PA , US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Thomas Jefferson University Hospital , Philadelphia, PA , US"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"2024040305571717800_CIT0001","article-title":"SEER*Explorer: an interactive website for SEER cancer statistics","volume-title":"Data source(s): SEER Incidence Data, November 2022 Submission (1975-2020), SEER 22 registries","author":"Surveillance Research Program, National Cancer Institute","year":"2023"},{"key":"2024040305571717800_CIT0002","article-title":"SEER*Explorer: an interactive website for SEER cancer statistics","volume-title":"Data source(s): U.S. Mortality Data (1969-2020), National Center for Health Statistics, CDC","author":"Surveillance Research Program, National Cancer Institute","year":"2023"},{"volume-title":"Cervical cancer","year":"2022","key":"2024040305571717800_CIT0003"},{"key":"2024040305571717800_CIT0004","first-page":"378","article-title":"Adequacy in endocervical curettage","volume-title":"Am J Clin Pathol.","author":"Alqabbani","year":"2022"},{"key":"2024040305571717800_CIT0005","first-page":"132","article-title":"Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines","volume-title":"J Low Genit Tract Dis.","author":"Egemen","year":"2020"},{"key":"2024040305571717800_CIT0006","first-page":"1","article-title":"Does screening by \u201cPAP\u201d smears help prevent cervical cancer","volume-title":"Lancet.","author":"Clarke","year":"1979"},{"key":"2024040305571717800_CIT0007","first-page":"727","article-title":"Natural history of cervical squamous intraepithelial lesions: a meta-analysis","volume-title":"Obstet Gynecol.","author":"Melnikow","year":"1998"},{"key":"2024040305571717800_CIT0008","first-page":"149","article-title":"HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests","volume-title":"J Am Soc Cytopathol","author":"Ge","year":"2019"},{"key":"2024040305571717800_CIT0009","first-page":"633","article-title":"Cellularity of liquid-based, thin-layer cervical cytology slides","volume-title":"Acta Cytol.","author":"Bishop","year":"2002"},{"key":"2024040305571717800_CIT0010","first-page":"168","article-title":"Using a quality control approach to define an \u201cadequately cellular\u201d liquid-based cervical cytology specimen","volume-title":"Cytopathology.","author":"McQueen","year":"2006"},{"key":"2024040305571717800_CIT0011","first-page":"605","article-title":"Effect of cellularity on the sensitivity of detecting squamous lesions in liquid-based cervical cytology","volume-title":"Acta Cytol.","author":"Studeman","year":"2003"},{"key":"2024040305571717800_CIT0012","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-11074-5","volume-title":"The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes","author":"Nayar","year":"2015"},{"key":"2024040305571717800_CIT0013","first-page":"2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume-title":"JAMA.","author":"Solomon","year":"2002"},{"key":"2024040305571717800_CIT0014","first-page":"474","article-title":"Should adequacy criteria in cervicovaginal cytology be modified after radiotherapy, chemotherapy, or hysterectomy","volume-title":"Cancer Cytopathol","author":"Lu","year":"2010"},{"issue":"4","key":"2024040305571717800_CIT0015","first-page":"643","article-title":"Recent developments in understanding the immune response to human papilloma virus infection and cervical neoplasia","volume":"27","author":"Kobayashi","year":"2000","journal-title":"Oncol Nurs Forum."},{"key":"2024040305571717800_CIT0016","first-page":"1763","article-title":"Efficacy of cervical-smear collection devices: a systematic review and meta-analysis","volume-title":"Lancet.","author":"Martin-Hirsch","year":"1999"},{"issue":"3","key":"2024040305571717800_CIT0017","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0142(19990625)87:3<113::AID-CNCR3>3.0.CO;2-V","article-title":"The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities","volume":"87","author":"Mintzer","year":"1999","journal-title":"Cancer."},{"issue":"3","key":"2024040305571717800_CIT0018","first-page":"323","article-title":"Relationship between the diagnosis of epithelial abnormalities and the composition of cervical smears","volume":"29","author":"Vooijs","year":"1985","journal-title":"Acta Cytol."},{"key":"2024040305571717800_CIT0019","first-page":"1053","article-title":"Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry","volume-title":"Obstet Gynecol.","author":"Baer","year":"2002"},{"issue":"6","key":"2024040305571717800_CIT0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1309\/RP84-MD34-8MFN-39UR","article-title":"Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears","volume":"115","author":"Bos","year":"2001","journal-title":"Am J Clin Pathol."},{"issue":"3","key":"2024040305571717800_CIT0021","first-page":"258","article-title":"Papanicolaou smears without endocervical cells: are they inadequate","volume":"30","author":"Kivlahan","year":"1986","journal-title":"Acta Cytol."},{"key":"2024040305571717800_CIT0022","first-page":"265","article-title":"Longitudinal study of women with negative cervical smears according to endocervical status","volume-title":"Lancet.","author":"Mitchell","year":"1991"},{"key":"2024040305571717800_CIT0023","first-page":"237","article-title":"Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status","volume-title":"Cancer.","author":"Mitchell","year":"2001"},{"issue":"2","key":"2024040305571717800_CIT0024","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/1097-0339(200102)24:2<79::AID-DC1014>3.0.CO;2-3","article-title":"Pap smear adequacy: is our understanding satisfactory . . . or limited","volume":"24","author":"Birdsong","year":"2001","journal-title":"Diagn Cytopathol."},{"key":"2024040305571717800_CIT0025","first-page":"368","article-title":"Differences between Papanicolaou smears with correct and incorrect diagnoses","volume-title":"Cytopathology.","author":"Mitchell","year":"1995"},{"key":"2024040305571717800_CIT0026","first-page":"155","article-title":"A case-control study of true-positive versus false-negative cervical smears in women with cervical intraepithelial neoplasia (CIN) III","volume-title":"Cytopathology.","author":"O\u2019Sullivan","year":"1998"},{"key":"2024040305571717800_CIT0027","first-page":"102","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume-title":"J Low Genit Tract Dis.","author":"Perkins","year":"2020"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/161\/4\/369\/57122923\/aqad157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/161\/4\/369\/57122923\/aqad157.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T05:59:02Z","timestamp":1712123942000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/161\/4\/369\/7456122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,30]]},"published-print":{"date-parts":[[2024,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqad157","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"type":"print","value":"0002-9173"},{"type":"electronic","value":"1943-7722"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2023,11,30]]}}}